Kevin B Kim

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Transcription Factor

Monoclonal Antibody

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical & experimental metastasis

This page only lists publications with an associated author ORCID identifier.

Publications

Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kevin B Kim
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches. Clinical & experimental metastasis (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Thein Swe, Kevin B Kim
Update on systemic therapy for advanced cutaneous melanoma and recent development of novel drugs. Clinical & experimental metastasis 35 (5-6) (2018)
Elham Vosoughi, Jee Min Lee, James R Miller, Mehdi Nosrati, David R Minor, Roy Abendroth, John W Lee, Brian T Andrews, Lewis Z Leng, Max Wu, Stanley P Leong, Mohammed Kashani-Sabet, Kevin B Kim
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies. BMC cancer 18 (1) (2018)